S&P 500 7718.60 -0.38%
NASDAQ 26506.99 -0.29%
TASI 11024.73 -0.40%
Oil (WTI) 91.48 +0.00%
Oil (Brent) 96.28 +0.00%
VIX 15.19 +4.54%
Gold 4476.60 +0.00%
USD/SAR 3.76 +0.02%

Veeva Systems Inc.

VEEV · Healthcare · · USD
275.09 USD
0.00 (-3.27%)
● Updated 2026-09-07 17:37 Saudi Time ↻ Refresh
Short-term Mid-term Long-term

Fahodi Score STRONG BUY Mid-term (Position)

86
/ 100
Technical 100
Trend & RS 96
Momentum 95
Fundamental 78
Macro 65
Liquidity 42
ComponentScoreWeight
Technical 100.0 20%
Trend & RS 96.4 30%
Momentum 94.7 15%
Fundamental 77.8 10%
Macro 64.6 20%
Liquidity 42.4 5%

Trade Setup

Entry 275.09
Stop Loss 253.33 (7.9%)
Target 1 (1:1) 296.85 (+7.9%)
Target 2 (2:1) 318.61 (+15.8%)
ATR(14) 10.88 (4.0%)
Risk per Share 21.76
Reward:Risk 2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor Score Z Bar
Value 25.9 -0.97
Momentum 94.7 +1.79
Quality 75.8 +1.03
Composite 65.5

Quality Scores

Piotroski F-Score 7 /9 — Strong
✓ ✓ ✗ ✗ ✓ ✓ ✓ ✓ ✓
1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover
Altman Z-Score Insufficient Data

Valuation vs Peers Overvalued

MetricStockSectorvs Peers
P/E Ratio 45.0 22.0 +105% above
P/B Ratio 6.1 4.0 Above

Comparing against Healthcare median multiples.

Trading at a premium to sector peers — verify growth justifies premium.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value
143.55
vs
Market Price
275.09
Upside
-47.8%
Margin of Safety -91.6%
Stage 1 PV (5yr FCF)4,998,223,955
Terminal Value PV18,243,845,441
Total Enterprise Value23,242,069,396

Assumptions

Base FCF791,410,406
Growth Rate (5yr)17.6%
Terminal Growth2.5%
Discount Rate (WACC)9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%
Recommended Size
54.71%
Full Kelly
27.35%
Half Kelly
5.0%
Max Cap (Moderate)

Kelly inputs derived from quant score 86/100. Estimated win rate 66%, avg win 10.2%, avg loss 3.3%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

4
Bullish Signals
0
Bearish Signals
65.92
RSI(14)
18.4318
MACD

Relative Strength (RS) IMPROVING

90
/ 99
RS Rating
✓ O'Neil PASS (≥80)
RS vs SPY ↑ RISING (+54.7% vs SPY 3M)
RS vs Sector OUTPERFORMING (Healthcare)
RS New High No (4d since high)
Sector Outperformance +51.6% (3M)
RS Line — stock / SPY (90 bars)
← older newer →
RS vs SPY 50-day SMA of RS
IMPROVING: Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.

Technical Indicators

IndicatorValueSignal
Rsi 65.92 NEUTRAL
Macd 18.4318 BULLISH
Ma Cross 220.0 / 198.62 GOLDEN CROSS
Trend Short ABOVE SMA50
Trend Long ABOVE SMA200
Bollinger MIDDLE
Volume 0.59x NORMAL

Key Levels

LevelPrice
52-Week High310.50
Bollinger Upper293.78
SMA(200)198.62
SMA(50)220.0
SMA(20)257.19
Current Price275.09
Bollinger Lower220.6
52-Week Low148.05
ATR(14)10.88

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

MARKUP Confidence
100%
Acc: 0.0  |  Dist: 0.0  |  Markup: 2.0  |  Markdown: 0.0

Volume Spread Analysis (last 5 bars)

DateSignalVolDescription
2026-08-31 Normal 1.46x Normal bar — no special VSA pattern
2026-09-01 Normal 0.63x Normal bar — no special VSA pattern
2026-09-02 Normal 0.77x Normal bar — no special VSA pattern
2026-09-03 Normal 0.77x Normal bar — no special VSA pattern
2026-09-04 No Demand 0.59x Low volume, narrow spread, weak close — no buying interest

Ichimoku Cloud BULLISH

LineValueStatus
Tenkan-sen (9) 267.59 Above Kijun
Kijun-sen (26) 247.62 Base line
Senkou A 257.61 Leading span A
Senkou B 227.06 Leading span B
Cloud 227.06 – 257.61 Bullish (Green)
Price vs Cloud 275.09 Above Cloud
Chikou Span 203.78 Bullish
Alignment Score 4/4 BULLISH

TTM Squeeze & Divergences

TTM Squeeze

SQUEEZE OFF No squeeze Momentum: BULLISH FADING
BB: 220.6 – 293.78  |  KC: 240.59 – 273.79

Divergences (last 60 bars)

TypeIndicatorBars AgoStrength
Regular Bearish RSI 5
Regular Bearish MACD 5
Hidden Bullish RSI 8

Anchored VWAP

VWAP: 185.53 Anchor: 2026-04-10 (52w Low) ABOVE AVWAP +48.3%

Heikin-Ashi Trend

WEAKLY BEARISH Full data via /api/advanced/VEEV

Valuation

MetricValue
Market Cap44.54B
P/E (TTM)45.02
Forward P/EN/A
P/B6.14
EPS6.11

Financial Health

MetricValue
Revenue Growth17.6%
Profit Margin29.3%
ROE14.4%
Debt/Equity2.04
Current Ratio5.46
Dividend YieldN/A
Payout RatioN/A
Beta0.97

Trading Data

275.09
Open
275.09
Day High
275.09
Day Low
1.15M
Volume (0.6x avg)

Recent News (8)

Why Is Veeva Systems (VEEV) Winning Big In AI For Biopharma?
Simply Wall St. · 2026-09-04
VEEV Raises FY27 Outlook as Vault CRM and AI Momentum Accelerate Fast
Zacks · 2026-09-03
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
Zacks · 2026-09-03
Michael Burry Warns Red-Hot AI Stock Is Overvalued
GuruFocus.com · 2026-09-03
Michael Burry Sends Fresh Warning on Surging Tech Stock
GuruFocus.com · 2026-09-03
Michael Burry Calls Snowflake Overvalued as Shares Jump 23%
GuruFocus.com · 2026-09-03
Here's How Much You'd Have If You Invested $1000 in Veeva Systems a Decade Ago
Zacks · 2026-09-03
Michael Burry Stays Bullish On VEEV, Calls SNOW 'Overvalued' — And Revisits 'Big Short' Thesis That Best Stocks Fall By Half First
Stocktwits · 2026-09-03

Price Chart (90 Days)

Candlesticks (green=up, red=down) SMA 20 SMA 50 Bollinger Bands (upper/lower) Volume (green=buying, red=selling)
Powered by Fahodi Methodology. This is analytical output, not financial advice. Always do your own due diligence.  ·  Pipeline status  ·  Data: —